BR0312537A - Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta - Google Patents

Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta

Info

Publication number
BR0312537A
BR0312537A BR0312537-8A BR0312537A BR0312537A BR 0312537 A BR0312537 A BR 0312537A BR 0312537 A BR0312537 A BR 0312537A BR 0312537 A BR0312537 A BR 0312537A
Authority
BR
Brazil
Prior art keywords
whey protein
control
adhering
animals
aid
Prior art date
Application number
BR0312537-8A
Other languages
English (en)
Inventor
Cinderella Christina Gerhardt
Maria Catherine Tasker
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29797302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0312537(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR0312537A publication Critical patent/BR0312537A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Fodder In General (AREA)
  • Cosmetics (AREA)

Abstract

"USOS DE HIDROLISATO DE PROTEìNA DE SORO EM COMPOSIçãO COMESTìVEL, MéTODO DE INDUçãO DA SACIEDADE EM SERES HUMANOS OU ANIMAIS E MéTODO DE MELHORIA OU CONTROLE DA PERCEPçãO DA IMAGEM DO CORPO E/OU CONTROLE DO PESO DO CORPO E/OU CONTROLE DA INGESTãO DE CALORIAS E/OU AUXìLIO NA ADESãO A UM PLANO DE DIETA". A presente invenção fornece o uso de proteína de soro e/ou hidrolisato de proteína de soro que estimulam a liberação celular dos peptídeos de saciedade coleocistoquinina e peptídeo similar a glucagon na preparação de composições comestíveis. As composições comestíveis podem ser utilizadas para controlar o peso do corpo e possuem efeitos benéficos sobre a saciedade. Também são fornecidas composições comestíveis.
BR0312537-8A 2002-07-01 2003-06-13 Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta BR0312537A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02254622 2002-07-01
PCT/EP2003/006212 WO2004002241A1 (en) 2002-07-01 2003-06-13 Satiety inducing composition

Publications (1)

Publication Number Publication Date
BR0312537A true BR0312537A (pt) 2005-04-19

Family

ID=29797302

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312537-8A BR0312537A (pt) 2002-07-01 2003-06-13 Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta

Country Status (12)

Country Link
US (1) US7618648B2 (pt)
EP (1) EP1517619B1 (pt)
JP (1) JP2005538704A (pt)
CN (1) CN100352374C (pt)
AT (1) ATE349918T1 (pt)
AU (1) AU2003242695B2 (pt)
BR (1) BR0312537A (pt)
CA (1) CA2489942A1 (pt)
DE (1) DE60310934T2 (pt)
ES (1) ES2280796T3 (pt)
MX (1) MXPA04012394A (pt)
WO (1) WO2004002241A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
JP2005538704A (ja) 2002-07-01 2005-12-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 満腹誘導組成物
WO2004056207A1 (en) * 2002-12-20 2004-07-08 Unilever N.V. Blood glucose regulating composition
WO2005023021A1 (ja) * 2003-09-02 2005-03-17 Bbk Bio Corporation ダイエット食品
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US7931693B2 (en) * 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
US8585771B2 (en) 2004-02-26 2013-11-19 Endosphere, Inc. Methods and devices to curb appetite and/or to reduce food intake
BRPI0508181A (pt) * 2004-04-02 2007-08-07 Univ Tennessee Res Foundation componentes de laticìnio eficazes para a perda de gordura
EP1616489A1 (de) * 2004-07-10 2006-01-18 Cognis IP Management GmbH Nahrungsergänzungsmittel
DK1831361T3 (da) 2004-12-23 2012-05-14 Campina Nederland Holding Bv Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse
EP1888086A4 (en) * 2005-04-11 2009-09-16 Univ Tennessee Res Foundation STABLE MILK PRODUCT COMPONENTS WITH FAT REDUCING EFFECT
EP1874796A4 (en) * 2005-04-26 2012-04-11 Ambryx Biotechnology Inc COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OVERWEIGHT OR ADIPOSITAS WITH ZINC-LOADED PROTEIN FRAGMENTS
FR2887122B1 (fr) * 2005-06-17 2011-02-11 Gervais Danone Sa Produits laitiers frais a pouvoir satietogene et procedes de preparation
US9233075B2 (en) * 2005-08-09 2016-01-12 Metacure Limited Satiety
US8486469B2 (en) * 2005-10-17 2013-07-16 Intercontinental Great Brands Llc Low-calorie food bar
US8431531B2 (en) 2005-11-30 2013-04-30 Campina Nederland Holding B.V. Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same
WO2007123200A1 (ja) * 2006-04-21 2007-11-01 Meiji Seika Kaisha, Ltd. ペプチドを有効成分として含有する組成物
US9060835B2 (en) 2006-05-26 2015-06-23 Endosphere, Inc. Conformationally-stabilized intraluminal device for medical applications
US7989007B2 (en) * 2007-07-03 2011-08-02 Vincent James Enterprises, Llc Weight loss composition
US20110137227A1 (en) 2007-07-16 2011-06-09 Mckinley James T Methods and devices for delivering or delaying lipids within a duodenum
JP2012513771A (ja) * 2008-12-31 2012-06-21 ソレイ リミテッド ライアビリティ カンパニー Ｃｃｋ放出能力が増強されたタンパク質加水分解組成物
JP5735734B2 (ja) * 2009-04-16 2015-06-17 雪印メグミルク株式会社 脂質代謝改善剤
US20100278981A1 (en) * 2009-04-22 2010-11-04 Gary Ervin Meal Replacement and Appetite Control/ Diet System
CA2771027C (en) * 2009-08-14 2019-03-12 General Mills Ip Holdings Ii, Llc Cooking of salt free or reduced salt breakfast cereals
JP2011184314A (ja) * 2010-03-04 2011-09-22 Snow Brand Milk Products Co Ltd 筋肉萎縮防止剤
US20110287134A1 (en) * 2010-05-18 2011-11-24 Gary Ervin Chocolate dietary fiber supplement and delivery method
WO2012087486A1 (en) * 2010-12-20 2012-06-28 Hill's Pet Nutrition, Inc. Pet food compositions for inducing a satiety response
WO2012141795A1 (en) * 2011-02-23 2012-10-18 Solae, Llc Protein hydrolysate compositions having enhanced cck and glp-1 releasing activity
FR2981544B1 (fr) * 2011-10-25 2014-01-31 Internat Nutrition Res Company Produit dietetique destine a la prevention du risque cardiometabolique
WO2015091739A2 (en) * 2013-12-18 2015-06-25 Thylabisco Ab Use of thylakoids to reduce the urge for palatable food
US20160242450A1 (en) * 2014-07-29 2016-08-25 Rey Magana Functional-gel Compositions and Methods
CN107405310A (zh) * 2014-12-15 2017-11-28 安纳生物科技有限公司 耐胃微胶囊及其在刺激哺乳动物内回肠glp‑1释放的用途
USD767242S1 (en) 2015-09-03 2016-09-27 The J.M Smucker Company Coated food product
USD767243S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767244S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767241S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
US20190216125A1 (en) * 2016-09-29 2019-07-18 Nestec S.A. Methods that reduce food cravings, promote weight loss, and/or treat overweight or obesity
JPWO2019139113A1 (ja) * 2018-01-12 2021-01-07 株式会社明治 Ｇｌｐ−１分泌促進用栄養組成物
CN108936260A (zh) * 2018-07-31 2018-12-07 上品（洛阳）牡丹产业有限公司 一种多功能牡丹籽粕蛋白代餐粉及其制备方法
EP3960202A4 (en) * 2019-04-26 2023-01-18 Suntory Holdings Limited COMPOSITION PROMOTING THE SECRETION OF GLP-1
CN110477128B (zh) * 2019-09-12 2023-01-10 福建长富乳品有限公司 一种高钙乳清饮料的制备方法及其产品
WO2021083958A1 (en) * 2019-10-29 2021-05-06 Specialites Pet Food Novel peptides inducing satiety
US11389499B2 (en) 2020-01-22 2022-07-19 David Phillip Lang High fiber nutritional compositions with improved organoleptic characteristics for better diet management

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321603A1 (fr) 1987-12-23 1989-06-28 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
DK0493850T3 (da) 1990-12-28 1994-08-15 Unilever Plc Forbedrede, dybfrosne, for-raskede dejprodukter
WO1993004593A1 (en) * 1991-08-30 1993-03-18 Teagasc, The Agriculture And Food Development Authority Hypoallergenic whey protein hydrolysate
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5821217A (en) 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
WO1997039641A1 (en) 1996-04-18 1997-10-30 M.D. Foods A.M.B.A. Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
IL127684A0 (en) 1996-07-17 1999-10-28 Nicada Inc Composition for appetite suppression
EP1065947B1 (en) * 1998-03-31 2003-04-23 Societe Des Produits Nestle S.A. Use of a composition for providing glutamine
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6630320B1 (en) * 2000-05-08 2003-10-07 Devisco Foods International, Inc. Treatment of hypertension in mammals with hydrolyzed whey proteins
US20020061359A1 (en) * 1999-07-23 2002-05-23 Baker Lois A. High-foaming, stable modified whey protein isolate
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
WO2001043563A1 (de) * 1999-12-17 2001-06-21 N.V. Nutricia Verwendung von modifizierten lebensmittelinhaltsstoffen zur vorbeugung der entwicklung eines diabetes mellitus (iddm) bei bestehendem epidemiologisch begründetem risiko
EP1112693B1 (en) 1999-12-30 2006-03-22 Kerry Group Services Ltd Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
JP2004519204A (ja) 2000-05-08 2004-07-02 ダビスコ フーズ インターナショナル インコーポレーテッド 抗高血圧ペプチドの生成のための乳漿タンパク質の酵素処理、得られた産物、および哺乳動物における高血圧の処置
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US6809115B2 (en) * 2000-09-21 2004-10-26 Nutrition 21, Inc. Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
ATE328491T1 (de) * 2000-10-24 2006-06-15 Campina Melkunie Bv Peptiden reich an cystein und/oder glycin
EP1281325A1 (en) * 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
JP2005538704A (ja) 2002-07-01 2005-12-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 満腹誘導組成物
AU2003265010A1 (en) 2002-09-16 2004-04-30 Quest International Services B.V. Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
AU2003302675A1 (en) 2002-11-29 2004-06-23 Unilever Plc Beverage product with modified starch and nitrogen
AU2003288036A1 (en) 2002-11-29 2004-06-23 Unilever Plc Beverage with foam maintaining system
WO2004056207A1 (en) 2002-12-20 2004-07-08 Unilever N.V. Blood glucose regulating composition
ATE477812T1 (de) * 2003-02-07 2010-09-15 Campina Bv Verwendung von tryptophanreichen peptiden aus molkenproteinhydrolysate zur behandlung von übergewicht und fettleibigkeit
ATE397453T1 (de) 2003-06-30 2008-06-15 Nestec Sa Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
WO2007116091A1 (en) 2006-04-12 2007-10-18 Dsm Ip Assets B.V. Novel nutraceutical compositions

Also Published As

Publication number Publication date
EP1517619A1 (en) 2005-03-30
MXPA04012394A (es) 2005-02-25
ATE349918T1 (de) 2007-01-15
EP1517619B1 (en) 2007-01-03
AU2003242695B2 (en) 2007-12-06
CN1665404A (zh) 2005-09-07
CN100352374C (zh) 2007-12-05
ES2280796T3 (es) 2007-09-16
WO2004002241A1 (en) 2004-01-08
JP2005538704A (ja) 2005-12-22
AU2003242695A1 (en) 2004-01-19
US20050238694A1 (en) 2005-10-27
US7618648B2 (en) 2009-11-17
DE60310934D1 (de) 2007-02-15
DE60310934T2 (de) 2007-10-11
CA2489942A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
BR0312537A (pt) Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta
DK0759944T3 (da) Forbedringer af og relateret til peptidfremføring
PT1090033E (pt) Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
CY1114030T1 (el) Ομοιογενη παρασκευασματα toy il-29
CA2358423A1 (en) A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
WO1999008708A3 (en) Method and food product for increasing muscle protein and reducing fat in animals
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
BRPI0407533A (pt) proteìnas de fusão e muteìnas do interferon alfa com propriedades melhoradas
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
WO2000077034A3 (en) Amino acids from fish and soy proteins improve insulin sensitivity
BR0207018A (pt) Leptina modificada com imunogenicidade reduzida
BR0207015A (pt) Eritropoientina modificada (epo) com imunogenicidade reduzida
BR0207704A (pt) Alfa interferon modificado com imunogenicidade reduzida
ATE96982T1 (de) Zusammensetzung zur herstellung von kuenstlicher milch fuer kaelber und daraus hergestellte kuenstliche milch fuer kaelber.
BR0207014A (pt) Antagonista de receptor de interleucina-1 modificada (il-1ra) com imunogenicidade reduzida.
BR0207905A (pt) Protamina modificada com imunogenicidade reduzida
BR9916549A (pt) Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
DE60235418D1 (de) Osteoprotegerin in Milch
NZ504532A (en) Use of cement proteins derived from ticks as glues for animal tissues and as vaccinations against tick borne diseases
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
BR112022020438A2 (pt) Composições compreendendo três proteínas de fusão ospa para uso médico
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
BR0207020A (pt) Fator de estimulação de colÈnia por granulócito (g-csf) modificado com imunogenicidade reduzida
WO2001051512A3 (en) Human and parasite orphan receptor proteins

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDA DE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE 8.6 DA RPI 2112 DE 28/06/2011.

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/19 (2016.01), A23L 33/18 (2016.01), A23L 3